Reinfection with SARS-CoV-2 after Aortic Valve Replacement for Infective Endocarditis

Document Type : Case Report


1 Department of Cardiovascular Surgery, Abderrahmen Mami Pneumology and Phthisiology Hospital, Ariana, Tunisia.

2 Department of Cardiology, Abderrahmen Mami Pneumology and Phthisiology Hospital, Ariana, Tunisia.


Although the COVID-19 pandemic started over 2 years ago, the uncertainty regarding the management of this severe disease continues to prevail. We describe a patient with aortic valve endocarditis complicated by COVID-19 postoperatively. Given increased symptom severity during reinfection, it is important to highlight the need for the long-term follow-up of these patients since they might be prone to another episode of COVID-19. (Iranian Heart Journal 2023; 24(3): 108-110)


  1. Long Q., Tang X., Shi Q. et al: Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med, 2020; 26(8):1200–4
  2. Erichsen P., Gislason G.H.,. Bruun N.E, The increasing incidence of infective endocarditis in Denmark, 1994–2011, Eur J Inter Med, 2016; 35:95–99
  3. Kirkcaldy RD, King BA, Brooks JT. COVID-19 and post infection immunity: limited evidence, many remaining questions. JAMA. 2020; 323(22):2245-2246
  4. Zhu L, Xu X, Ma K et al: Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression. Am J Transplant, 2020; 20(7):1859-1863
  5. Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020; 7(6):e438–e440